國立高雄大學圖資館 |

語系: 繁體中文

說明(常見問題)

圖資館首頁

登入

回首頁

切換: 標籤 | MARC模式 | ISBD

Pathophysiology of ischemia reperfus...

Ahmed, Naseer,

Pathophysiology of ischemia reperfusion injury and use of fingolimod in cardioprotection

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	Pathophysiology of ischemia reperfusion injury and use of fingolimod in cardioprotectionNaseer Ahmed.
作者:	Ahmed, Naseer,
出版者:	London :Academic Press, an imprint of Elsevier,2019.
面頁冊數:	1 online resource :ill., map
標題:	Reperfusion injuryPathophysiology.
電子資源:	https://www.sciencedirect.com/science/book/9780128180235
ISBN:	9780128182536 (electronic bk.)

Pathophysiology of ischemia reperfusion injury and use of fingolimod in cardioprotection
Ahmed, Naseer,

Pathophysiology of ischemia reperfusion injury and use of fingolimod in cardioprotection[electronic resource] /Naseer Ahmed. - London :Academic Press, an imprint of Elsevier,2019. - 1 online resource :ill., map

Includes bibliographical references and index.

Pathophysiology of Ischemia-Reperfusion Injury and Use of Fingolimod in Cardioprotection is a deep examination into the mechanisms of myocardial ischemiareperfusion injury and role of fingolimod as a cardioprotective agent through its antioxidant, anti-apoptotic and anti-inflammatory effects. Dr. Ahmed explore the physiology and pathophysiology of myocardial metabolism under normal and ischemic conditions and focused on pharmacological cardioprotection. They provide aconcise, yet rigorous discussion of Ischemia-Reperfusion Injury, Myocardial Ischemia during Circulatory Arrest, Myocardial Reperfusion, Myocardial Protection related to Ischemia-Reperfusion Injury and Role of Fingolimod in Cardioprotection.Pathophysiology of Ischemia-Reperfusion Injury and Use of Fingolimod in Cardioprotection is ideal for researchers, cardiovascular scientists, and clinical pharmacologists to further work in this challenging area and apply this knowledge toclinical trials for cardioprotection.

ISBN: 9780128182536 (electronic bk.)Subjects--Topical Terms:

897092
Reperfusion injury
--Pathophysiology.Index Terms--Genre/Form:

214472
Electronic books.

LC Class. No.: RB144.5

Dewey Class. No.: 616.1/3

National Library of Medicine Call No.: 2019 F-778

Pathophysiology of ischemia reperfusion injury and use of fingolimod in cardioprotection
LDR:01940cmm a2200277 a 4500 001 601681
006 m o d
007 cr cnu|||unuuu
008 211110s2019 enkab gob 001 0 eng d
020 $a 9780128182536 (electronic bk.)
020 $a 0128182539 (electronic bk.)
020 $a 9780128180235
020 $a 0128180234
035 $a (OCoLC)1103605858
035 $a on1103605858
040 $a N $b eng $c N $d N $d EBLCP $d OPELS $d UKMGB $d OCLCF $d UKAHL $d OCLCQ $d ERF $d LVT $d UX1 $d VT2 $d OCLCO $d OCLCA
041 0 $a eng
050 4 $a RB144.5
060 0 0 $a 2019 F-778
060 1 0 $a WG 282
082 0 4 $a 616.1/3 $2 23
100 1 $a Ahmed, Naseer, $e author. $3 897091
245 1 0 $a Pathophysiology of ischemia reperfusion injury and use of fingolimod in cardioprotection $h [electronic resource] / $c Naseer Ahmed.
260 $a London : $b Academic Press, an imprint of Elsevier, $c 2019.
300 $a 1 online resource : $b ill., map
504 $a Includes bibliographical references and index.
520 $a Pathophysiology of Ischemia-Reperfusion Injury and Use of Fingolimod in Cardioprotection is a deep examination into the mechanisms of myocardial ischemiareperfusion injury and role of fingolimod as a cardioprotective agent through its antioxidant, anti-apoptotic and anti-inflammatory effects. Dr. Ahmed explore the physiology and pathophysiology of myocardial metabolism under normal and ischemic conditions and focused on pharmacological cardioprotection. They provide aconcise, yet rigorous discussion of Ischemia-Reperfusion Injury, Myocardial Ischemia during Circulatory Arrest, Myocardial Reperfusion, Myocardial Protection related to Ischemia-Reperfusion Injury and Role of Fingolimod in Cardioprotection.Pathophysiology of Ischemia-Reperfusion Injury and Use of Fingolimod in Cardioprotection is ideal for researchers, cardiovascular scientists, and clinical pharmacologists to further work in this challenging area and apply this knowledge toclinical trials for cardioprotection.
650 0 $a Reperfusion injury $x Pathophysiology. $3 897092
650 0 $a Ischemia. $3 389171
650 0 $a Immunosuppressive agents. $3 509535
650 1 2 $a Myocardial Reperfusion Injury $x physiopathology. $3 897093
650 2 2 $a Fingolimod Hydrochloride $x therapeutic use. $3 897094
650 2 2 $a Myocardial Ischemia. $3 606808
650 7 $a HEALTH & FITNESS $x Diseases $x General. $2 bisacsh $3 571422
650 7 $a MEDICAL $x Clinical Medicine. $2 bisacsh $3 537581
650 7 $a MEDICAL $x Diseases. $2 bisacsh $3 571423
650 7 $a MEDICAL $x Evidence-Based Medicine. $2 bisacsh $3 571676
650 7 $a MEDICAL $x Internal Medicine. $2 bisacsh $3 571677
655 0 $a Electronic books. $2 local. $3 214472
856 4 0 $u https://www.sciencedirect.com/science/book/9780128180235